Alar Pharmaceuticals Inc. (TPEX:6785)
281.00
+3.00 (1.08%)
Dec 5, 2025, 1:30 PM CST
Alar Pharmaceuticals Revenue
Alar Pharmaceuticals had revenue of 1.25M TWD in the twelve months ending September 30, 2025, down -99.74% year-over-year. In the year 2024, Alar Pharmaceuticals had annual revenue of 5.82M, down -98.76%.
Revenue (ttm)
1.25M
Revenue Growth
-99.74%
P/S Ratio
14,980.69
Revenue / Employee
46.41K
Employees
27
Market Cap
18.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.82M | -463.46M | -98.76% |
| Dec 31, 2023 | 469.27M | 468.47M | 58,559.00% |
| Dec 31, 2022 | 800.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 600.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| EirGenix | 936.18M |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |